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Abstract 
Novel polymer biomaterials, which can be used in contact with blood, are prepared with strong inspiration from the 
surface structure of cell membranes. That is, the polymers with a phospholipid polar group in the side chain,               
2-methacryloyloxyethyl phosphorylcholine (MPC) polymers were synthesized. The MPC polymers can inhibit 
surface-induced clot formation effectively, when they are in contact with blood even in the absence of an 
anticoagulant. This phenomenon was due to the reduction of plasma protein and suppression of denaturation of 
adsorbed proteins, that is the MPC polymers interact with blood components very mildly. As the molecular structure 
of the MPC polymer was easily designed by changing the monomer units and their composition, it could be applied 
to surface modification of artificial organs and biomedical devices for improving blood and tissue compatibility. 
Thus, the MPC polymers are useful polymer biomaterials for manufacturing high performance artificial organs and 
biomedical devices to provide safe medical treatments. 
 
© 2012 Published by Elsevier Ltd.  
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1.  Bioinspired Concept for Preparing Phospholipid Polymers 
     The cell membrane is a sophisticated, nanostructured separator in living organisms. The membrane is 
mainly composed of phospholipid molecules, which play an important role in dividing intracellular 
cytoplasm from the outer environment, and glycoproteins as receptor and membrane penetrate proteins 
are also faced on the surface (Figure 1). The phospholipids have hydrophobic alkyl chains and a 
hydrophilic and a hydrophilic polar group, and they are spontaneously associated as a continuous 
membrane in an aqueous medium. The association shows unique characteristics not only in biological 
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aspects but also in physicochemical functions. The favourable characteristics of the cell membrane are as 
follows: (i) it has the mechanical strength to keep cell morphology; (ii) it has the ability to maintain 
concentration of specific chemicals in the cytoplasm and (iii) it can act as a scaffold for functional 
membranes with proteins and glycoproteins. In living organisms, the cell membrane is also utilized as an 
important communication interface between cell-cell junctions. Higher-ordered associates at the 
nanoscale would be excellent for expressing several kinds of functions. The cell membrane structure is 
the most attractive candidate for the fabrication of nanostructured biomaterials, which involves bio-, 
nano-, and information-technologies. The phospholipid molecule is the fundamental unit in the 
construction of the cell membrane. In particular, one of the major phospholipid polar groups on the cell 
membrane is phosphorylcholine, which is an electrically neutral, zwitterionic head group. In biomimetic 
chemistry, phospholipid molecules have been used in the preparation of the cell membrane-like structures 
such as liposomes, as drug delivery carriers. However, the major disadvantage of the liposome is 
chemical and/or physical stability. In this review, bioinspired phospholipid polymers for biomedical 
applications are systematically summarized. These phospholipid polymers are not biomimetic polymers 
but bioinspired polymers. The bioinspired approach to nanostructured biomaterials is widely applicable in 
the preparation of biointerfaces, bioconjugations, and biomatrices. The phospholipid monomers and 
polymers were prepared with attention to the chemical structure of phospholipid molecules and 
researched from an organic synthesis and polymerization perspective.  
 
 
Fig. 1.  Molecular design of 2-methacryloyloxyethyl phosphorylcholine (MPC) polymers by bioinspired concept 
2.  Synthesis of 2-Methacryloyloxyethyl Phosphorylcholine Polymers 
Synthesis of the phospholipid monomers was attempted; however, the purity and yield of the 
monomers were not enough to justify investigating them further as polymer materials. In 1990, Ishihara  
et al. reported the significant functions of phospholipid polymer materials in the biomedical field and 
successfully synthesized phospholipid monomers with higher yield and excellent purity [1]. The 
representative monomer, 2-methacryloyloxyethyl phosphorylcholine (MPC), is methacrylate with 
phosphorylcholine unit as a phospholipid polar group, whose synthetic route and chemical structure are 
shown in Figure 2. The MPC can polymerize and copolymerize with other vinyl compounds by a 
conventional radical polymerization [2].  Also, progress of polymerization science provides well-defined 
MPC polymer via living radical polymerization [3,4]. Most of the bioinspired phospholipid polymer 
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chemistry has been based on the novel phospholipid monomer; natural unsaturated phospholipid, styrene 
derivatives with phospholipid polar group, and methacrylate derivatives with phospholipid polar group, 
and has been widely examined to create many functions in living systems such as a stimuli-responsive 
function; recognition, processing, and transformation of outer environment. However, the amount of 
phospholipid monomer synthesis would regulate the research activity for application. In the case of MPC, 
1 kg of the monomer could be synthesized on laboratory scale per year in 1990. In those days, the major 
research on MPC polymer chemistry was on the interfacial properties of MPC polymer coating. In 1999, 
MPC was prepared on an industrial scale [by Nippon Oil and Fats (NOF) Co., Ltd, Tokyo, Japan], and the 
amount of MPC produced was roughly 10 tons. Thus, recent phospholipid polymers based on MPC 
polymer chemistry has been recognized worldwide [5,6]. The bioinspired approach using phospholipid 
polymers has the potential to develop many kinds of biomaterials and medical devices. 
 
Fig. 2.  Technical transfer of synthetic procedure of MPC from laboratory to industry 
3.  Preparation of Biocompatible Surface by Coating of the MPC Polymer 
Polymer coating is a valuable surface modification technique for preparation of biomedical devices. 
Generally, biomedical devices are assembled from a large number of complicated parts; organs such as 
artificial hearts and artificial lungs are typical models. There are two processes in the coating; one is a dip 
coating and the other is a spin coating. In the case of dip coating, the devices are simply immersed into 
the polymer solution directly, and then all of the devices are available for coating (thickness of coating: 
30-100 nm). On the other hand, a very nice thin coating layer is obtained by spin coating (thickness of 
coating: below 30 nm). The devices are spun on the spin coater apparatus, which coating process would 
be one of regulation for the coating treatment. In this chapter, coatings with phospholipid polymers are 
described in terms of interfacial characterization and biological application. Protein adsorption on a 
biomaterial in contact with a body fluid and blood is a regular phenomenon. The amount of protein 
adsorption dominates biocompatibility and blood compatibility. Therefore, surface modification is an 
important technique for the improvement of compatibility. Many attempts have been made, using various 
approaches, for example, physicochemical, interfacial chemical, biochemical, and biological. Among 
them, a coating with phospholipid polymers is the most effective approach not only in reducing protein 
adsorption but also in maintaining biological function as shown in Figure 3. The nanometer-scaled 
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phospholipid polymer layers provided a novel bioinspired interface; the evaluation of reducing protein 
adsorption by the phospholipid polymer has been energetically investigated since early 1990 [7-9].  
The mechanism of reducing proteins was discussed. Ishihara et al. hypothesized that the mechanism of 
reduction of protein adsorption was discussed in terms of water structure on the phospholipid polymer 
coating surface [10]. Lu et al. clearly explained the protein adsorption on the polymer surface by structure 
of water molecule; bound water and free water [11]. Generally, proteins and polymer surfaces have a 
fraction of bound water, which is shared between them. The tightly adsorbed proteins, owing to sharing 
bound water molecules, would be denatured by the conformational change. The water fraction of the 
polymer surface was evaluated using DSC to determine the level of water structure. The free water 
showed an exothermic peak around 0 °C, and the free water fraction was calculated to the water content 
in equilibrium state. In the case of 0.36 hydration [(weight of water in the polymer)/(weight of polymer 
saturated with water)], the MPC polymer showed 0.69 of free water fraction whereas poly(2-hydroxyethyl 
methacrylate) [poly(HEMA)] showed only 0.28. This result indicated that the hydrated MPC polymer had 
a large amount of free water fraction. 
 
Fig. 3. Surface biocompatibility of the MPC polymer-coated surface 
Furthermore, the highly free water surface would provide stabilization of biomolecules such as enzyme 
and protein, even when the biomolecules adsorbed on the surface. Ishihara et al. proved the stabilization 
of bovine serum albumin (BSA) by using circular dichroism (CD) spectra. In the CD spectra, the native 
BSA in phosphate-buffered solution (PBS) showed negative value of the mean molar residual ellipticity 
(T) from 205 to 250 nm [10]. The obtained molar ellipticity at 208 and 222 nm indicated the secondary 
structure of BSA; D-helix structure and E-sheet structure, respectively. In the case of BSA adsorbed on 
the MPC polymer-coating surface, the molar ellipticity showed almost the same spectrum, which 
indicated native BSA. Poly(HEMA) coating surface, which showed the lower free water fraction, showed 
significant difference spectrum. The content of the D-helix and E-sheet structures decreased with 
adsorption of protein solution. BSA adsorption on the poly(HEMA) surface (1.7 Pg/cm2) was eight times 
that on the MPC polymer surface (0.22 Pg/cm2). The adsorbed protein would be denatured by 
hydrophobic hydration following the adsorption of higher protein by the sharing of bound water. Due to 
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this, the bioinspired MPC polymer surface provided a higher fraction of free water, and the suppression of 
biomolecules adsorption and the stabilization of their properties were achieved. 
When poly(MPC) brush surface was prepared, amount of protein adsorbed on the surface was less than 
5 ng/cm2 [12] . This value is less than the minimum amount of proteins, which platelets adhere and 
activate to induce thrombus formation. 
4.  Development of Artificial Organs Using The MPC Polymers 
We have developed a novel artificial joint with poly(MPC) grafted onto the surface of cross-linked 
polyethylene (CLPE), which is used as a liner of artificial joint [13]. The poly(MPC) graft layer with  
100-150 nm in thickness was formed on the CLPE surface. This layer markedly decreased the friction and 
the wear of CLPE, which was revealed on 7u107 cycles hip simulator test. This new type artificial hip 
joint system (Aquala®, Japan Medical Materials) has been implanted to patients in Japan.  
The other MPC polymers have been applied to develop some medical devices such as cardiovascular 
stent (Endeavor®: Medtronic), left ventricular assist device (EVAHEART®, Sun Medical) oxygenator 
(PrimO2x®: Sorin), and soft contact lenses (Proclear®: Cooper Vision). 
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